Please provide your email address to receive an email when new articles are posted on . FluMist is now approved for self- or caregiver-administration for people aged 2 to 49 years. The nasal spray is ...
The U.S. Food and Drug Administration approved the first flu vaccine on Friday, which does not have to be administered by a health care provider, but it won’t be available in time for this respiratory ...
AstraZeneca’s Supplemental Biologics License Application for the approval of a self- or caregiver-administered option for Flumist Quadrivalent (Influenza Vaccine Live, Intranasal), a needle-free nasal ...
The US Food and Drug Administration is reviewing an application for the nasal spray flu vaccine FluMist to be able to be self-administered at home, drugmaker AstraZeneca said Tuesday. The vaccine, the ...
The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...